Noel Doheny, CEO of Epigenomics, spoke with me during Tomorrow Can’t Wait, the 2017 Colorectal Cancer Alliance conference. Epigenomics has developed the first FDA  and PMA approved liquid biopsy test to screen for colorectal cancer.

The post A Blood Test to Screen For Colorectal Cancer? Epigenomics Has It appeared first on The Colon Cancer Podcast.